Stockscreener 앱 받기
26.01
0.73%
-0.19
시간 외 거래:
26.05
0.04
+0.15%
전일 마감가:
$26.20
열려 있는:
$26.25
하루 거래량:
187.84K
Relative Volume:
3.05
시가총액:
$926.20M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.76%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$25.61
$26.48
1주일 범위
$25.02
$26.90
52주 변동 폭
$24.10
$27.71
Ceribell Inc Stock (CBLL) Company Profile
Ceribell Inc 주식(CBLL)의 최신 뉴스
A&O Shearman advises on initial public offering of Ceribell, Inc. - A&O Shearman
Ceribell’s stock soars 36% in trading debut after pricing IPO at top of range - MSN
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 - WV News
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell: An Interesting EEG Play Going Public (NASDAQ:CBLL) - Seeking Alpha
TPG GP A, LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell EEG system linked to improved patient outcomes - Investing.com India
Ceribell EEG system linked to improved patient outcomes By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock - Investing.com
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG - PR Newswire
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PR Newswire
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO - Fierce Biotech
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
CeriBell (NASDAQ: CBLL) Stock Soars On Debut Trading: Here are Key Drivers - DRP Journal
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN
CeriBell, EEG developer, sees stock rally 35% following $180M IPO - MSN
CeriBell Goes Public in Rare Medical-Device IPO - The Wall Street Journal
Latham & Watkins Advises CeriBell on Upsized IPO - ILW.com
CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq - Fast Company
Ceribell begins trading with upsized IPO - BioWorld Online
CeriBell, Inc. Rings the Closing Bell - Nasdaq
Ceribell Up 49% in Debut After Upsized IPO - MarketWatch
Neurotech company CeriBell prices $180.3M IPO - Mass Device
CeriBell, EEG developer, sees stock rally 35% following $180M IPO (NASDAQ:CBLL) - Seeking Alpha
Ceribell Opens At $23.26, IPO Priced At $17 By Investing.com - Investing.com Australia
CeriBell Releases Price Of Upsized Initial Public Offering - MPO-mag
CeriBell prices IPO at $17 per share - MSN
Upstream Bio, two other U.S. biotech startups price IPOs as healthcare listings rise - Reuters
CBLL IPO NewsSeizure diagnostic company CeriBell prices IPO at $17, the high end of the upwardly revised range - Renaissance Capital
CeriBell Shares Set for Trading Debut After Pricing IPO at High End of Views - MarketWatch
CeriBell Prices Upsized 10.61M Share IPO at $17/sh - Investing.com India
CeriBell Prices Upsized 10.61M Share IPO at $17/sh By Investing.com - Investing.com Canada
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering - StockTitan
TPG-backed CeriBell seeks up to $578 million valuation in upsized US IPO - MSN
Preview: Ceribell, Inc Set To IPO Tomorrow - Benzinga
CeriBell seeks up to $578 million valuation in upsized US IPO - WTAQ
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs - MSN
TPG-backed CeriBell seeks up to $578 mln valuation in upsized US IPO - Reuters
CeriBell, Inc Files for Upsized 10.6M Share IPO at a Higher $16-$17/sh Price Range - Investing.com India
CeriBell seeks up to $578 mln valuation in upsized US IPO - XM
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs (Pending:UPB) - Seeking Alpha
Ceribell Seeks Public Debut with $101M IPO Amid Medtech IPO Struggles - MD+DI
Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO - Fierce Biotech
CeriBell, Inc Files for 6.7M Share IPO at $14-$16/sh - Investing.com
New technology helps with seizure detection - KING5.com
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.23%
1.94%
자본화:
|
볼륨(24시간):